SCHEMBL510219

SCHEMBL510219

COCCC(N)OC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28114894 0.82
Hydrochloric Acid SCHEMBL27517080 0.81
SCHEMBL2126808 0.76
SCHEMBL10169512 0.76
SCHEMBL15966054 0.76
SCHEMBL18829419 0.75
SCHEMBL4581130 0.75
SCHEMBL30566566 0.75
SCHEMBL4830064 0.75 PIK3CD (0.35)
SCHEMBL15966055 0.74 MAPK1 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109280046-A Benzimidazoles derivative and preparation method thereof and its purposes in medicine 浙江海正药业股份有限公司 2019-01-29 CN disclosed
US-9173893-B2 Purine nucleoside monophosphate prodrugs for treatment of cancer and viral infections COCRYSTAL PHARMA, INC. (US) 2015-11-03 US disclosed
US-8815829-B2 3′-azido purine nucleotide prodrugs for treatment of viral infections RFS PHARMA, LLC (US) 2014-08-26 US disclosed
US-20140235566-A1 PYRIMIDINE NUCLEOSIDES AND THEIR MONOPHOSPHATE PRODRUGS FOR TREATMENT OF VIRAL INFECTIONS AND CANCER EMORY UNIVERSITY (US) 2014-08-21 US disclosed
US-20140066395-A1 PURINE NUCLEOSIDE MONOPHOSPHATE PRODRUGS FOR TREATMENT OF CANCER AND VIRAL INFECTIONS EMORY UNIVERSITY (US) 2014-03-06 US disclosed
US-20120142627-A1 MONOPHOSPHATE PRODRUGS OF DAPD AND ANALOGS THEREOF EMORY UNIVERSITY (US) 2012-06-07 US disclosed
US-20120040924-A1 PURINE NUCLEOSIDE MONOPHOSPHATE PRODRUGS FOR TREATMENT OF CANCER AND VIRAL INFECTIONS EMORY UNIVERSITY (US) 2012-02-16 US disclosed
US-20120028979-A1 2-(PIPERIDIN-1-YL)-4-HETEROCYCLYL-THIAZOLE-5-CARBOXYLIC ACID DERIVATIVES AGAINST BACTERIAL INFECTIONS ASTRAZENECA AB (SE) 2012-02-02 US disclosed
EP-1611131-B1 PYRAZOLOPYRIDINE DERIVATES PALAU PHARMA SA (ES) 2010-09-15 EP disclosed